News About: Pharm. Industry
Boryung to build GMP plant in 2011
Boryung Pharm is planning to build its plant at a complex to be created at Yesan of South Chooncheon Province in 2011.
Boryung officials said the plant will give an industrial edge to the whole Boryung affliliates....
Leading toothbrush brand to go on sale
Dong-A Pharm will join the local toothbrush market with an exclusive marketing right of Jordan, No. 1 brand in the Northern Europe.
The company is expected to generate a bigger sale with the renowned brand in the y...
Ildong to release hyaluronic acid as finished form
Ildong Pharm is in a final stage to develop hyaluronic acid, company official said.
The company is set to produce the finished products by 2011 in Chunju plant and seek to boost the sales in the overseas market.
...
Wyeth urged to mend fences with Daewoong
Wyeth Pharmaceuticals will have to seek a win-win game with Daewoong Pharm as their relations have turned sour since the stern refusal of Wyeth over the development of novel anti-infective agent, according to market o...
Boryung wins patent nullification trial over Arimidex
The local patent trial board has recently ruled against AstraZeneca’s Arimidex (anastrozole) patent in its nullification trial which has been sought by Boryung Pharm.
Anastrozole is a drug used to treat breast canc...
Safety concerns growing over adjuvanted vaccines
As concern over the safety of flu vaccines increases, a lawmaker feel a local drug company is putting profit above public safety, according to a lawmaker.
Currently, Korean drug-maker Green Cross Corp. has produced...
Price cut sparks Levitra shortage
The significant price reduction of Levitra (vardenafil) 10 mg, an erectile dysfunction medicine, is becoming an increasing boon for Bayer Healthcare Korea ― so much so that they're having trouble keeping up with deman...
Drug makers, wholesalers urged to promote more concerted efforts
In the current environment of pricing pressure, it is essential for pharmaceutical firms and wholesaler to strengthen their mutual cooperation, market analysts say.
As things stand, the high profitability of pharma...
Daewoong, Wyeth are at odds over new drug agreement
Daewoong Pharm said on November 30 the company plans to appeal the International Arbitration Court over the dispute arising from the Wyeth Pharmaceutical’s unilateral cancellation of the contract between a biopharmace...
Green Cross names new executives in shake-up
Green Cross Corporation (GCC), the local leading pharmaceutical maker, said on November 30 that it promoted Huh Il-sub, incumbent vice chairman, as its chairman
The country’s leading vaccine maker also appointed t...
